664 related articles for article (PubMed ID: 16125946)
1. Expression of neurotrophin receptors in surgically resected thymic epithelial tumors.
Kim DJ; Yang WI; Kim SH; Park IK; Chung KY
Eur J Cardiothorac Surg; 2005 Oct; 28(4):611-6. PubMed ID: 16125946
[TBL] [Abstract][Full Text] [Related]
2. Proliferative activity and apoptosis in thymic epithelial neoplasms.
Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
[TBL] [Abstract][Full Text] [Related]
3. Steroid receptor expression in thymomas and thymic carcinomas.
Mimae T; Tsuta K; Takahashi F; Yoshida A; Kondo T; Murakami Y; Okada M; Takeuchi M; Asamura H; Tsuda H
Cancer; 2011 Oct; 117(19):4396-405. PubMed ID: 21437890
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophin receptor immunoreactivity in the hippocampus of patients with mesial temporal lobe epilepsy.
Ozbas-Gerçeker F; Gorter JA; Redeker S; Ramkema M; van der Valk P; Baayen JC; Ozgüç M; Saygi S; Soylemezoglu F; Akalin N; Troost D; Aronica E
Neuropathol Appl Neurobiol; 2004 Dec; 30(6):651-64. PubMed ID: 15541005
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors.
Sogawa K; Kondo K; Fujino H; Takahashi Y; Miyoshi T; Sakiyama S; Mukai K; Monden Y
Cancer; 2003 Nov; 98(9):1822-9. PubMed ID: 14584061
[TBL] [Abstract][Full Text] [Related]
6. p75 and TrkC neurotrophin receptors demonstrate a different immunoreactivity profile in comparison to TrkA and TrkB receptors in human normal pituitary gland and adenomas.
Assimakopoulou M; Zolota V; Chondrogianni C; Gatzounis G; Varakis J
Neuroendocrinology; 2008; 88(2):127-34. PubMed ID: 18319596
[TBL] [Abstract][Full Text] [Related]
7. [Surgery for thymomas and thymic carcinomas; treatment results in terms of WHO histologic typing, Masaoka staging system, and p53 expression].
Yamazaki K; Kitada M; Sasaki K; Koshiko S; Hirasawa M; Ozawa K; Kajiura Y; Sasajima T; Miyokawa N
Kyobu Geka; 2002 Oct; 55(11):949-52. PubMed ID: 12391691
[TBL] [Abstract][Full Text] [Related]
8. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3?
Laeng RH; Eimoto T; Kuo TT; Zettl A; Marx A; Moschopulos M; Tateyama H; Shimokawa K
Pathol Res Pract; 2006; 202(10):697-704. PubMed ID: 16887284
[TBL] [Abstract][Full Text] [Related]
9. WHO histologic classification is a prognostic indicator in thymoma.
Kondo K; Yoshizawa K; Tsuyuguchi M; Kimura S; Sumitomo M; Morita J; Miyoshi T; Sakiyama S; Mukai K; Monden Y
Ann Thorac Surg; 2004 Apr; 77(4):1183-8. PubMed ID: 15063231
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of the WHO histological classification of thymoma.
Sonobe S; Miyamoto H; Izumi H; Nobukawa B; Futagawa T; Yamazaki A; Oh T; Uekusa T; Abe H; Suda K
Ann Thorac Cardiovasc Surg; 2005 Dec; 11(6):367-73. PubMed ID: 16401984
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR.
Bibel M; Hoppe E; Barde YA
EMBO J; 1999 Feb; 18(3):616-22. PubMed ID: 9927421
[TBL] [Abstract][Full Text] [Related]
12. Expression of proteasome subunit β5t in thymic epithelial tumors.
Yamada Y; Tomaru U; Ishizu A; Kiuchi T; Marukawa K; Matsuno Y; Kasahara M
Am J Surg Pathol; 2011 Sep; 35(9):1296-304. PubMed ID: 21836487
[TBL] [Abstract][Full Text] [Related]
13. [Clinical outcome of epithelial tumors of the thymus].
Tsukada H; Koike J; Osada H
Kyobu Geka; 2002 Oct; 55(11):936-41. PubMed ID: 12391689
[TBL] [Abstract][Full Text] [Related]
14. Correlations among neural cell adhesion molecule, nerve growth factor, and its receptors, TrkA, TrkB, TrkC, and p75, in perineural invasion by basal cell and cutaneous squamous cell carcinomas.
Chen-Tsai CP; Colome-Grimmer M; Wagner RF
Dermatol Surg; 2004 Jul; 30(7):1009-16. PubMed ID: 15209791
[TBL] [Abstract][Full Text] [Related]
15. Type B thymoma: is prognosis predicted only by World Health Organization classification?
Kim HK; Choi YS; Kim J; Shim YM; Han J; Kim K
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1431-1435.e1. PubMed ID: 20038470
[TBL] [Abstract][Full Text] [Related]
16. [Results of surgical treatment for thymic epithelial tumors with special reference to the WHO classification].
Fujinaga K; Takao M; Sai M; Inoue K; Yada M; Hirano K; Yada I; Shiraishi T
Kyobu Geka; 2002 Oct; 55(11):921-5. PubMed ID: 12391686
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological character and long-term results of thymic epithelial tumor categorized by WHO classification].
Nakamura H; Taniguchi Y; Ohgi S
Kyobu Geka; 2002 Oct; 55(11):931-5. PubMed ID: 12391688
[TBL] [Abstract][Full Text] [Related]
18. Expression of podoplanin in thymoma: its correlation with tumor invasion, nodal metastasis, and poor clinical outcome.
Tateyama H; Sugiura H; Yamatani C; Yano M
Hum Pathol; 2011 Apr; 42(4):533-40. PubMed ID: 21237498
[TBL] [Abstract][Full Text] [Related]
19. Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas.
Sadohara J; Fujimoto K; Müller NL; Kato S; Takamori S; Ohkuma K; Terasaki H; Hayabuchi N
Eur J Radiol; 2006 Oct; 60(1):70-9. PubMed ID: 16766154
[TBL] [Abstract][Full Text] [Related]
20. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
